© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Reply
Vitamin D compounds in chronic kidney disease: change may be needed for good!
1 Department of Medicine, University of Otago, Christchurch, New Zealand 2 Mario Negri Sud, Italy
| The first 150 words of the full text of this article appear below. |
Sir,
Over the last half a century, we have come to appreciate the importance of vitamin D prescription for people with renal disease. Vitamin D and its analogues have profoundly altered the natural history of deforming ‘renal rickets’. Observational studies have found significant associations between use of vitamin D compounds and improved survival [1,2]. We have now become convinced by clinical and experimental evidence that the abnormalities of calcium, phosphorus and parathyroid hormone observed in chronic kidney disease are associated with increased mortality [3–5]. Some of these abnormalities may be affected by treatment with vitamin D compounds. Our guidelines [6] have therefore reflected the need to target improvement of biochemical targets, including parathyroid hormone, phosphorus and calcium, which implies use of both pharmacological (vitamin D and its analogues, calcimimetics and phosphate binders) and non-pharmacological strategies (long-hours dialysis and dietary restriction). The management of bone
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. B. Drueke and E. Ritz Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet and/or Vitamin D Derivatives Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 234 - 241. [Abstract] [Full Text] [PDF]
|
|